Effect of atracurium versus cisatracurium on QT interval changes in patients undergoing cataract surgery

Effect of atracurium versus cisatracurium on QT interval changes in patients undergoing cataract surgery: a double-blind randomized clinical trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120215009014N441

Enrollment

Registered

2022-09-10

Start date

2022-09-23

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract. Age-related cataract

Interventions

Intervention 1: Intervention group 1: Injection of atracurium 0.25 mg/kg single dose 5 minutes after induction of anesthesia. Intervention 2: Intervention group 2: Injection of cisatracurium 0.5 mg/kg

Eligibility

Sex/Gender

All

Age

40 Years to 80 Years

Inclusion criteria

Inclusion criteria: Age of 40 to 80 years Candidate for undergoing cataract surgery

Exclusion criteria

Exclusion criteria: Prolonged QT interval syndrome Using medications affecting QT interval

Design outcomes

Primary

Measure	Time frame
Assessing the QT interval. Timepoint: Before anesthesia, 5 minutes after the injection and at the end of surgery and recovery. Method of measurement: Using electrocardiogram.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Ghaheri

Hamedan University of Medical Sciences

ali.ghaheri2009@gmail.com+98 81 3838 0572

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 5, 2026